An article published in the scientific journal Viruses, showed the results of the antiviral efficacy in the pre-clinical phase against Influenza A of the polyphenol epigallocatechin-3-gallate (EGCG). EGCG is one of the components of green tea.

This study is the result of joint research between Australian and Canadian entities, including the Collaborating Center for Reference and Research on Influenza of the World Health Organization (WHO).

The results of this research are part of the development of
influenza antiviral medications, which are important tools in the fight against annual influenza epidemics and pandemics.

Consult the full text article at the following link:

Stannard, H.; Koszalka, P.; Deshpande, N.; Desjardins, Y.; Baz, M. Pre-Clinical Evaluation of the Antiviral Activity of Epigalocatechin-3-Gallate, a Component of Green Tea, against Influenza A(H1N1)pdm Viruses. Viruses 2023, 15, 2447.

You will find more articles n our Tea Benefits section